Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Higher dose of Rebif approved in E.U. for multiple sclerosis

April 15, 1999

Serotonergic agents for depression under study at BASF

April 14, 1999

IP receptor antagonists from Roche with potential as analgesic/antiinflammatory agents

April 13, 1999

Organon Teknika licenses potent analgesic from Delta

April 12, 1999

ADIR prepares structurally novel compounds as venotropic agents

April 12, 1999

PEG used to repair cut nerve fibers in animal models

April 12, 1999

Phase Ib trial of NBI-34060 successfully completed by Neurocrine Biosciences

April 9, 1999

Novel anticonvulsants described by RCT

April 9, 1999

Trega's analgesic effective in postoperative pain study

April 9, 1999

First launch for RiboGene's intranasal metoclopramide

April 8, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...